Yini Ye
University of Hong Kong
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yini Ye.
Life Sciences | 2003
Yini Ye; H.L. So; Edgar S.L. Liu; Vivianyvonne Shin; C. H. Cho
Our previous study showed that a crude extract from Angelica sinensis (ASCE), which mainly consisted of polysaccharides, significantly promoted migration and proliferation of normal gastric epithelial cells. These results strongly suggest that ASCE has a direct wound healing effect on gastric mucosa. However, there is no report concerning the effect of ASCE on gastric ulcer healing in animal models. In this study, we found that ASCE promoted ulcer healing. The area of the ulcer was reduced. This was accompanied with a significant increase in mucus synthesis when compared with the control. Angiogenesis was inhibited by the treatment of ASCE. Cell proliferation, ODC and EGFR protein expression was not affected in this process. Thus, the mechanism of how ASCE accelerates ulcer healing in addition to its effect on mucus synthesis remains to be investigated.
European Journal of Pharmacology | 2001
Xin Guo; Edgar S.L. Liu; Joshua Ka-Shun Ko; Benjamin C.Y. Wong; Yini Ye; Shiu Kum Lam; C. H. Cho
Clinical and experimental findings had indicated that cigarette smoke exposure, and cyclooxygenase-2, are strongly associated with inflammatory bowel disease. The present study aimed to evaluate the role of cyclooxygenase-2 in the pathogenesis of experimental inflammatory bowel disease as well as in the adverse action of cigarette-smoke exposure. Rats were pretreated with different cyclooxygenase-2 inhibitors (indomethacin, nimesulide, or SC-236 (4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide)) along with cigarette-smoke exposure before 2,4,6-trinitrobenzenesulfonic acid-enema. Results indicated that pretreatment with cyclooxygenase-2 inhibitors not only protected against 2,4,6-trinitrobenzenesulfonic acid-induced inflammatory bowel disease, but also attenuated the potentiating effect of cigarette-smoke exposure on colonic damage. Furthermore, the colonic cyclooxygenase-2 protein and mRNA expression was markedly induced by 2,4,6-trinitrobenzenesulfonic acid-enema, and it was potentiated further by cigarette-smoke exposure, while the cyclooxygenase-1 expression was not changed. The present study suggests that the highly induced cyclooxygenase-2 expression not only plays a pathogenic role in 2,4,6-trinitrobenzenesulfonic acid-induced inflammatory bowel disease, but also contributes to the adverse action of cigarette-smoke exposure on this disorder.
Cancer Investigation | 2007
Edgar S.L. Liu; Yini Ye; Vivian Y. Shin; William Ka Kei Wu; Benjamin Chun-Yu Wong; C. H. Cho
The interactions of cigarette smoking with COX-2 on colitis and colitis-associated adenoma formation were studied. Mice were induced with colitis and exposed to cigarette smoke (CS) and/or SC236 (a COX-2 inhibitor). Results indicated that CS did not alter acute colonic inflammation. Addition of SC236 abolished the induction of proliferation and oxidative damage by colitis. Chronic SC236 treatment abolished the promoting effect of CS on colonic adenoma formation, via suppression of COX-2- and VEGF-mediated proliferation and angiogenesis, and reversed bcl-2-mediated inhibition of apoptosis by CS. To conclude, COX-2 inhibitor could be an implication on cancer prevention in smokers with chronic colitis.
Carcinogenesis | 2005
Yini Ye; William Ka Kei Wu; Vivianyvonne Shin; I.C. Bruce; Benjamin C.Y. Wong; Chi Hin Cho
Carcinogenesis | 2004
Vivian Y. Shin; William Ka Kei Wu; Yini Ye; Wallace H.L. So; Marcel W.L. Koo; Edgar S.L. Liu; Jiing-Chyuan Luo; C. H. Cho
Journal of Pharmacology and Experimental Therapeutics | 2003
Yini Ye; Edgar S.L. Liu; Vivianyvonne Shin; William Ka Kei Wu; Jiing-Chyuan Luo; C. H. Cho
Toxicology | 2004
Yini Ye; Edgar S.L. Liu; Vivianyvonne Shin; William Ka Kei Wu; C. H. Cho
European Journal of Pharmacology | 2004
Jiing-Chyuan Luo; Vivianyvonne Shin; Edgar S.L. Liu; Yini Ye; William Ka Kei Wu; Wallace H.L. So; Full-Young Chang; C. H. Cho
Journal of Pharmacology and Experimental Therapeutics | 2004
Yini Ye; Edgar S.L. Liu; Vivianyvonne Shin; William Ka Kei Wu; C. H. Cho
Carcinogenesis | 2003
Edgar S.L. Liu; Yini Ye; Vivian Y. Shin; Siu Tsan Yuen; Suet-Yi Leung; Benjamin C.Y. Wong; C. H. Cho